Results 121 to 130 of about 59,724 (178)

Designed miniproteins potently inhibit and protect against MERS-CoV. [PDF]

Cell Rep
Ragotte RJ, Tortorici MA, Catanzaro NJ, Addetia A, Coventry B, Froggatt HM, Lee J, Stewart C, Brown JT, Goreshnik I, Sims JN, Milles LF, Wicky BIM, Glögl M, Gerben S, Kang A, Bera AK, Sharkey W, Schäfer A, Harkema JR, Baric RS, Baker D, Veesler D.   +22 more
europepmc   +1 more source

MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18. [PDF]

Front Immunol
Zhang Y, Stevenson NJ.
europepmc   +1 more source

MERS CoV: A trigger for healthcare transformation

Journal of Infection and Public Health, 2016
openaire   +2 more sources

MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures. [PDF]

J Virol
Chiok KL, Jenik K, Fenton M, Falzarano D, Dhar N, Banerjee A.   +5 more
europepmc   +1 more source

Recurrent MERS-CoV Transmission in Saudi Arabia- Renewed Lessons in Healthcare Preparedness and Surveillance. [PDF]

J Epidemiol Glob Health
Al-Tawfiq JA, Memish ZA.
europepmc   +1 more source

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults. [PDF]

Nat Commun
Mayer L, Fathi A, Weichel HM, Raadsen MP, Dahlke C, Mykytyn A, Rodon J, Gerresheim GK, Te Marvelde MR, Weskamm LM, Grewe I, Schlesner C, Lütgehetmann M, Drosten C, Becker S, Haagmans BL, Hardtke S, Addo MM.   +17 more
europepmc   +1 more source

Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses. [PDF]

Front Microbiol
Pan L, Kaku Y, Tolentino JE, Kosugi Y, Sato K.   +4 more
europepmc   +1 more source

A Narrative Review on the Recent Insights Into the Pathogenicity and Potential Role of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in the Emergence of "Disease X". [PDF]

Health Sci Rep
Ahmed Z, Prattay KMR, Sharmin S, Fatema-Tuz-Zohora, Raj A, Faruk FB, Ahmed B, Omer HBM, Omi AA, Rabbi F, Bahar NB, Mou SS, Islam M, Karim E, Al-Mamun ME.   +14 more
europepmc   +1 more source

Antiviral efficacy of silicon nitride against SARS-CoV-2 and MERS-CoV: implications for PPE innovation. [PDF]

Front Microbiol
Heath BN, Woodson CM, McMinn C, Bock RM, Kehn-Hall K.   +4 more
europepmc   +1 more source